Editorial: Novel biomarkers for clinical and molecular stratification of organ involvement in rheumatic diseases

Xiaolin Sun; Miao Pan

doi:10.3389/fmed.2023.1274950

Editorial: Novel biomarkers for clinical and molecular stratification of organ involvement in rheumatic diseases

Front Med (Lausanne). 2023 Aug 28:10:1274950. doi: 10.3389/fmed.2023.1274950. eCollection 2023.

Authors

Xiaolin Sun¹, Miao Pan^{2

3}

Affiliations

¹ Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
² Division of Pathology and Laboratory Medicine, Children's National Hospital, Washington, DC, United States.
³ Departments of Pathology and Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC, United States.

No abstract available

Keywords: biomarker; molecular stratification; organ involvement; precision medicine; rheumatic disease.

Publication types

Editorial

Grants and funding

XS was supported by National Natural Science Foundation of China (81971520 and 82171775) and Peking University People's Hospital Research and Development Funds (RDGS2022-05). MP was supported by a grant from National Institutes of Health (1U01HG011745 and 1UG3TR004033).